Published in Lancet Oncol on August 01, 2005
Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ (2007) 3.30
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat (2007) 1.55
Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea. BMC Cancer (2016) 1.39
Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer (2006) 1.30
Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol (2008) 1.17
Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med (2012) 1.05
Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis. BMC Womens Health (2008) 1.01
Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study. Breast Cancer Res (2008) 0.99
Decline in hormone replacement prescription and fall in breast cancer incidence: an epidemiological discourse. Dtsch Arztebl Int (2008) 0.99
Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol (2011) 0.91
Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy. Chin J Cancer Res (2012) 0.89
Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women. Am J Epidemiol (2011) 0.83
A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium. Breast Cancer Res (2015) 0.82
Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control (2008) 0.82
Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study. BMJ (2014) 0.81
Hormonal therapy and risk of breast cancer in mexican women. PLoS One (2013) 0.79
New intrauterine technologies for contraception and treatment in -nulliparous/adolescent and parous women. Facts Views Vis Obgyn (2009) 0.79
Breast Cancer Risk Factors among Ugandan Women at a Tertiary Hospital: A Case-Control Study. Oncology (2016) 0.78
Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study. Cancer Causes Control (2016) 0.77
Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea. Medicine (Baltimore) (2016) 0.76
The breast cancer epidemic: 10 facts. Linacre Q (2014) 0.76
The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. Clin Med Insights Oncol (2011) 0.76
Oral contraceptive use and kidney cancer risk among women: evidence from a meta-analysis. Int J Clin Exp Med (2014) 0.75
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer. Lancet Oncol (2005) 0.75
Oral contraceptives, menopausal treatment, and cancer. Lancet Oncol (2007) 0.75
The contraceptive revolution: some excellent progress but work still to be done. Br J Gen Pract (2009) 0.75
Ethical diversity and the role of conscience in clinical medicine. Int J Family Med (2013) 0.75
Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods. PLoS One (2014) 0.75
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer. Lancet Oncol (2005) 0.75
Reproductive and hormonal risk factors of breast cancer: a historical perspective. Int J Womens Health (2017) 0.75
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
Carcinogenicity of human papillomaviruses. Lancet Oncol (2005) 5.84
Breast-cancer screening--viewpoint of the IARC Working Group. N Engl J Med (2015) 5.48
A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol (2009) 5.15
Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol (2007) 4.60
Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med (2010) 4.35
Effectiveness of tax and price policies in tobacco control. Tob Control (2010) 4.30
A review of human carcinogens--part D: radiation. Lancet Oncol (2009) 4.22
Carcinogenicity of alcoholic beverages. Lancet Oncol (2007) 3.98
Listing occupational carcinogens. Environ Health Perspect (2004) 3.57
Smokeless tobacco and cancer. Lancet Oncol (2008) 3.50
A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres. Lancet Oncol (2009) 3.47
Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol (2011) 3.18
Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. Lancet Oncol (2012) 3.00
The carcinogenicity of outdoor air pollution. Lancet Oncol (2013) 2.71
Commentary: mobile phones and cancer: next steps after the 2011 IARC review. Epidemiology (2014) 2.67
A review of human carcinogens--Part F: chemical agents and related occupations. Lancet Oncol (2009) 2.41
Preventable exposures associated with human cancers. J Natl Cancer Inst (2011) 2.14
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol (2009) 2.11
Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet Oncol (2013) 2.10
Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol (2005) 1.95
The science and practice of carcinogen identification and evaluation. Environ Health Perspect (2004) 1.89
Epidemiologic review of marijuana use and cancer risk. Alcohol (2005) 1.76
Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer (2011) 1.74
Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol (2008) 1.74
Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73
Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ (2009) 1.60
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60
Bladder cancer risk in painters: a meta-analysis. Occup Environ Med (2010) 1.57
Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect (2011) 1.51
Meeting report: summary of IARC monographs on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol. Environ Health Perspect (2005) 1.49